Latest NextCell Pharma News & Updates
See the latest news and media coverage for NextCell Pharma. We track all announcements, press releases, and industry mentions in real time, all in one place.
Swedish stem cell biotechnology company
nextcellpharma.com- Headquarters
- Huddinge, Sweden
- Founded year
- 2014
- Company type
- Public company
- Number of employees
- 15–50
Latest news about NextCell Pharma
Company announcements
-
NextCell Pharma publishes annual report 2024/2025
The annual report for the fiscal year 1 September 2024–31 December 2025 is available as an attachment or on the company's website. The share is traded on Nasdaq First North Growth Market under the short name NXTCL.
-
NextCell Pharma calls for annual general meeting
The meeting is held on May 27, 2026 in Huddinge with proposals on board election, incentive program and changes to the articles of association.
-
NextCell announces ProTrans phase II study accepted in Cytotherapy
The study evaluated safety and efficacy of ProTrans in covid-19 complications. It confirms short-term safety and the platform's robustness.
-
NextCell Pharma publishes Year-end Report 2024/2025
Operating revenues fell to 1 826 TSEK in Q4 and 10 181 TSEK for the year. New CFO takes up position. Directed new issue of 15 MSEK decided.
Media coverage
-
NextCell Pharma (year-end report review): Making progress | MarketScreener
Redeye’s analyst just published a Research Update on NextCell Pharma.Click here to read the articleMake sure to add NextCell Pharma to your Watchlist at Redeye...
-
NextCell Pharma AB: Seven-year follow-up data from ProTrans-Repeat demonstrate sustained disease-modifying effects of ProTrans in type 1 diabetes
NextCell Pharma AB ("NextCell" or the "Company") today announces long-term follow-up data from the ProTrans-Repeat study showing sustained preservation of endogenous insulin production in patients...
-
NextCell Pharma AB: NextCell Pharma publishes its Interim Report 4 2024/2025
About NextCell Pharma AB NextCell Pharma is a clinical-stage cell therapy company developing ProTrans, a patent-protected platform based on allogeneic mesenchymal stromal cells (MSCs) from...
-
NextCell Pharma AB: NextCell Pharma AB announces CFO transition
NextCell Pharma AB ("NextCell" or the "Company") today announces that the Company's CFO, Patrik Fagerholm, has decided to step down to take on a new...
Track NextCell Pharma and your other target companies to get real-time alerts and weekly summaries delivered straight to your inbox.
NextCell Pharma competitors & trending companies
Browse news for competitors to NextCell Pharma and other trending companies.
Diamyd Medical
Cellcolabs
Xintela
Mesoblast
Sironax
Aperture Therapeutics
Attentive
Klaviyo
Twilio
Insider One
Zeta Global
Iterable
Braze
Optimove
Bluecore
BlueConic
Amperity
Wero
BLIK
EPI
Swish
Affirm
Brite Payments
TCS
Overview Energy
Adfin
Ineffable Intelligence
Mechanize
Hexatronic
Alimak Group
Lindab Group
NYAB
Noon Energy
Nordan AI